Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
OncoImmunology
Volume 13, 2024 - Issue 1
Original Research
Peripheral CX3CR1+ T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer
, , , , , , , , , , , & 
show all
Yi Zhanga Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, China;c School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China;d Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-9861-4681View further author information
https://orcid.org/0000-0001-9861-4681View further author information show all